HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lars Videbæk Selected Research

Injections

1/2014Intracoronary injection of CD34-cells in chronic ischemic heart failure: 7 years follow-up of the DanCell study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lars Videbæk Research Topics

Disease

18Heart Failure
01/2022 - 01/2011
12Systolic Heart Failure
01/2022 - 06/2013
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 05/2014
3Breast Neoplasms (Breast Cancer)
01/2019 - 01/2017
3Aortic Valve Stenosis (Aortic Stenosis)
01/2016 - 05/2013
2Cardiomyopathies (Cardiomyopathy)
01/2022 - 10/2020
2Atrial Fibrillation
01/2022 - 05/2013
2Neoplasms (Cancer)
02/2018 - 01/2017
2Heart Diseases (Heart Disease)
01/2017 - 09/2011
2Coronary Artery Disease (Coronary Atherosclerosis)
09/2016 - 01/2016
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2022
1Inflammation (Inflammations)
01/2022
1Cardiac Sudden Death (Sudden Cardiac Arrest)
08/2019
1Left Ventricular Dysfunction
01/2019
1Cardiotoxicity
02/2018
1Unilateral Breast Neoplasms
01/2017
1Diabetes Mellitus
01/2016

Drug/Important Bio-Agent (IBA)

5empagliflozinIBA
01/2022 - 06/2019
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 10/2020
3SodiumIBA
01/2021 - 10/2020
3Brain Natriuretic Peptide (Natrecor)FDA Link
10/2020 - 06/2012
3Angiotensin Receptor AntagonistsIBA
01/2020 - 05/2013
2Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2021
2Natriuretic PeptidesIBA
01/2022 - 01/2021
2pro-brain natriuretic peptide (1-76)IBA
01/2022 - 10/2020
2Trastuzumab (Herceptin)FDA Link
01/2019 - 02/2018
2AnthracyclinesIBA
02/2018 - 01/2017
1Growth Differentiation Factor 15IBA
01/2022
1DiureticsIBA
01/2022
1IvabradineIBA
01/2020
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2020
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2020
1ReninIBA
01/2020
1Mineralocorticoid Receptor AntagonistsIBA
01/2020
1Sodium-Glucose Transport ProteinsIBA
06/2019
1Sodium-Glucose Transporter 2 InhibitorsIBA
06/2019
1Fluorouracil (Carac)FDA LinkGeneric
02/2018
1insulin receptor-related receptor (IRR)IBA
01/2017
1Glucagon-Like Peptide 1 (GLP 1)IBA
05/2014
1Hypoglycemic Agents (Hypoglycemics)IBA
05/2014
1LiraglutideFDA Link
05/2014
1OsteoprotegerinIBA
11/2013
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2013
1candesartanIBA
05/2013
1Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
09/2011
1CreatinineIBA
09/2011
1Antidepressive Agents (Antidepressants)IBA
01/2011

Therapy/Procedure

12Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
01/2022 - 01/2016
4Therapeutics
01/2021 - 01/2011
3Defibrillators (Defibrillator)
01/2022 - 01/2016
2Cardiac Resynchronization Therapy
01/2022 - 01/2016
2Radiotherapy
01/2017 - 01/2017
2Drug Therapy (Chemotherapy)
01/2017 - 06/2013
1Injections
01/2014